Acquired Blepharoptosis: Levation Pharma Launches Clinical Trial
MARCH 6, 2023
Levation Pharma has initiated a Phase I/II trial to evaluate the preliminary safety and potential efficacy of their investigational topical gel LEV102 for acquired blepharoptosis in adults. This is the first clinical trial that the company has launched for LEV102.
Let's personalize your content